Kimachi, Keiichiro

Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology Mar 2011 - 297-308 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1432-1912

10.1007/s00210-010-0596-4 doi


Acid Phosphatase--metabolism
Animals
Bone Marrow Cells--cytology
Bone Resorption--metabolism
Cell Differentiation--drug effects
Cell Line, Tumor
Cell Movement--drug effects
Diphosphonates--pharmacology
Diterpenes--pharmacology
Dose-Response Relationship, Drug
Gene Expression--drug effects
I-kappa B Proteins--metabolism
Imidazoles--pharmacology
Isoenzymes--metabolism
Macrophages--cytology
Mice
Mice, Inbred Strains
NF-KappaB Inhibitor alpha
NF-kappa B--metabolism
Osteoclasts--cytology
Phosphorylation--drug effects
Protein Prenylation--drug effects
RANK Ligand--pharmacology
Receptor Activator of Nuclear Factor-kappa B--genetics
Signal Transduction--drug effects
Stem Cells--cytology
Tartrate-Resistant Acid Phosphatase
Transcription, Genetic--drug effects
Tumor Necrosis Factor-alpha--pharmacology
Up-Regulation--drug effects
Zoledronic Acid